Variant report
Variant | esv13692 |
---|---|
Chromosome Location | chr6:161727258-161728794 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:161713190..161716483-chr6:161724342..161727800,3 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs75885191 | chr6:161727302-161727303 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs572079954 | chr6:161727344-161727345 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs77604296 | chr6:161727372-161727373 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs118148127 | chr6:161727383-161727384 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs561552743 | chr6:161727385-161727386 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs532477203 | chr6:161727406-161727407 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs146494406 | chr6:161727408-161727409 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs9347492 | chr6:161727415-161727416 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs531418873 | chr6:161727431-161727432 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs548270345 | chr6:161727444-161727445 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs544019488 | chr6:161727548-161727549 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs141112573 | chr6:161727557-161727558 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs564189005 | chr6:161727578-161727579 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs533721867 | chr6:161727715-161727716 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs11966409 | chr6:161727726-161727727 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs9458186 | chr6:161727792-161727793 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs540155268 | chr6:161727794-161727795 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs555983052 | chr6:161727796-161727797 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs556467709 | chr6:161727831-161727832 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs9295146 | chr6:161727837-161727838 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs77909096 | chr6:161727838-161727839 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs79005015 | chr6:161727841-161727842 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs62437628 | chr6:161727848-161727849 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs62437629 | chr6:161727857-161727858 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs62437630 | chr6:161727859-161727860 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs535674683 | chr6:161727863-161727864 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs555395206 | chr6:161727882-161727883 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs143207763 | chr6:161727885-161727886 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs11966445 | chr6:161727886-161727887 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs536966976 | chr6:161727914-161727915 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs12191683 | chr6:161727924-161727925 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs577039644 | chr6:161727925-161727926 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs9295147 | chr6:161727937-161727938 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs562786637 | chr6:161727950-161727951 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs537628878 | chr6:161727951-161727952 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs557208538 | chr6:161727970-161727971 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs62437631 | chr6:161727978-161727979 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs565188563 | chr6:161727980-161727981 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs561723518 | chr6:161728041-161728042 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs539517965 | chr6:161728065-161728066 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs373310357 | chr6:161728080-161728081 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs372583380 | chr6:161728105-161728106 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs550819624 | chr6:161728106-161728107 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs71544903 | chr6:161728107-161728108 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs79646251 | chr6:161728118-161728119 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs71004038 | chr6:161728120-161728121 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs116826834 | chr6:161728121-161728122 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs67215284 | chr6:161728125-161728126 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs547057788 | chr6:161728134-161728135 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs151224996 | chr6:161728148-161728149 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
Gastric cancer | 17908304 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Esophageal cancer | 21851588 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Breast cancer | 17133270 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Developmental delay | 21147756 | CNVD |
Chordoma | 18071362 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Autism | 22241247 | CNVD |
Breast cancer | 16397240 | CNVD |
Atherosclerosis | 21956041 | CNVD |
Maculopathy | 20981449 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Astrocytoma | 16205629 | CNVD |
Parkinson disease | 17160897 | CNVD |
Cancer | 20164920 | CNVD |
Breast cancer | 22522925 | CNVD |
Schizophrenia | 20838587 | CNVD |
Early-onset parkinson disease | 21993715 | CNVD |
Glioblastoma | 18772890 | CNVD |
Pancreatic cancer | 20981101 | CNVD |
Autism | 21360662 | CNVD |
Melanoma | 20877625 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:161722600-161727600 | Weak transcription | K562 | blood |
2 | chr6:161722600-161735800 | Weak transcription | Right Atrium | heart |
3 | chr6:161725600-161730200 | Weak transcription | HMEC | breast |
4 | chr6:161726800-161729000 | Enhancers | Brain Hippocampus Middle | brain |
5 | chr6:161727000-161727400 | Enhancers | Brain Substantia Nigra | brain |
6 | chr6:161727000-161728400 | Enhancers | Brain Cingulate Gyrus | brain |
7 | chr6:161727400-161728600 | Weak transcription | Brain Substantia Nigra | brain |
8 | chr6:161727600-161728000 | Enhancers | K562 | blood |
9 | chr6:161728000-161733800 | Weak transcription | K562 | blood |
10 | chr6:161728600-161728800 | Enhancers | Brain Substantia Nigra | brain |